Clinical Trial Update: SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating SGLT2 inhibitors as a potential treatment for pediatric Non-Alcoholic Fatty Liver Disease; the study is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Justin Ryder | Conditions: Non-Alcoholic Fatty Liver Disease, NAFLD | Phase 2 | Status: NOT_YET_RECRUITING